Anixa Biosciences is developing an innovative breast cancer vaccine that has completed Phase 1 clinical trials and is preparing for Phase 2 evaluation
Anixa Biosciences is developing an innovative breast cancer vaccine that has completed Phase 1 clinical trials and is preparing for Phase 2 evaluation